Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Dow
Harvard Business School
Johnson and Johnson
McKesson

Last Updated: December 9, 2021

DrugPatentWatch Database Preview

Litigation Details for Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Ferring B v. v. Watson Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .
Biologic Drugs cited in Ferring B v. v. Watson Laboratories Inc.
The biologic drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-05-01 27 6,051,253 A 4/2000 Zettler 6,066,339 A 512000 Stark et al. …may be divided into three doses of 6,066,339, which is expressly incorporated by reference … EXHIBIT~ 6,066,339 A 5/2000 Stark et al. …doses. As an example, a total daily dose 35 6,066,339, which is expressly incorporated by reference …infringement of the patents-in-suit in this case as well as a related patent, U.S. Patent No. 8,478,005. External link to document
2014-05-14 40 Ferring’s U.S. Patent Nos. 7,947,739 (“the ’739 patent”), 8,022,106 (“the ’106 patent”) and 8,273,795…The Asserted Patent Claims Claim 1 of the ’739 patent is illustrative of the patent claims at issue…regarding the patents at issue in this appeal, and an infringement claim regarding a different patent. …as Example 1 of the patents-in-suit, and its own ANDA documents and patent application detail …the asserted patent claims, and also meet the dissolution limitations of the patent claims. 3 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Baxter
Harvard Business School
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.